封面
市场调查报告书
商品编码
1732896

花生过敏治疗市场-全球产业规模、份额、趋势、机会和预测,按药物类别、给药途径、配销通路、地区和竞争细分,2020-2030 年

Peanut Allergy Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Class, By Route of Administration, By Distribution Channel, By Region and Competition, 2020-2030F

出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2024 年全球花生过敏治疗市场价值为 5.861 亿美元,预计到 2030 年将达到 12.102 亿美元,预测期内复合年增长率为 12.84%。人们对花生过敏的认识不断提高,加上技术的进步,推动了该市场的显着成长。花生过敏是一种危及生命的疾病,持续影响全球数百万人,导致对有效治疗方案的需求激增。对过敏机制的科学认识的提高促进了过敏原特异性免疫疗法和基于基因的治疗等标靶疗法的发展。该市场已引起製药公司和研究机构的关注,他们正在大力投资研发,以满足对创新和拯救生命的治疗解决方案日益增长的需求。

市场概览
预测期 2026-2030
2024年市场规模 5.861亿美元
2030年市场规模 12.102亿美元
2025-2030 年复合年增长率 12.84%
成长最快的领域 口服
最大的市场 北美洲

关键市场驱动因素

花生过敏症盛行率上升

主要市场挑战

治疗费用高昂

目录

第 1 章:产品概述

第二章:研究方法

第三章:执行摘要

第四章:顾客之声

第五章:全球花生过敏治疗市场展望

  • 市场规模和预测
    • 按价值
  • 市场占有率和预测
    • 依药物类别(抗组织胺、肾上腺素、免疫疗法、其他)
    • 依给药途径(口服、静脉注射、其他)
    • 按配销通路(零售药局、医院药局、网路药局)
    • 按地区
    • 按公司分类(2024)
  • 产品图
    • 按药物类别
    • 依给药途径
    • 按配销通路
    • 按地区

第六章:北美花生过敏治疗市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 北美:国家分析
    • 美国
    • 加拿大
    • 墨西哥

第七章:欧洲花生过敏治疗市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 欧洲:国家分析
    • 法国
    • 德国
    • 英国
    • 义大利
    • 西班牙

第八章:亚太花生过敏治疗市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 亚太地区:国家分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章:南美洲花生过敏治疗市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 南美洲:国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第十章:中东与非洲花生过敏治疗市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • MEA:国家分析
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋

第 11 章:市场动态

  • 驱动程式
  • 挑战

第 12 章:市场趋势与发展

  • 近期发展
  • 併购
  • 产品发布

第 13 章:全球花生过敏治疗市场:SWOT 分析

第 14 章:波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的力量
  • 顾客的力量
  • 替代产品的威胁

第 15 章:竞争格局

  • Vedanta Biosciences, Inc.
  • Alladapt Immunotherapeutics, Inc.
  • Regeneron Pharmaceuticals Inc.
  • Aravax Pty Ltd
  • Teva Pharmaceutical Industries Limited
  • Prota Therapeutics Pty Ltd.
  • Aimmune Therapeutics, Inc. (Nestle)
  • DBV Technologies SA
  • Sanofi SA
  • Mylan NV

第 16 章:策略建议

第17章调查会社について・免责事项

简介目录
Product Code: 15257

The Global Peanut Allergy Treatment Market was valued at USD 586.10 million in 2024 and is projected to reach USD 1210.20 million by 2030, registering a CAGR of 12.84% during the forecast period. The rising awareness about peanut allergies, coupled with technological advancements, is driving significant growth in this market. Peanut allergy is a life-threatening condition that continues to affect millions globally, prompting a surge in demand for effective treatment options. Improved scientific understanding of allergy mechanisms has enabled the development of targeted therapies such as allergen-specific immunotherapy and gene-based treatments. The market has garnered attention from pharmaceutical companies and research organizations that are investing extensively in R&D to capitalize on the growing need for innovative and life-saving treatment solutions.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 586.10 Million
Market Size 2030USD 1210.20 Million
CAGR 2025-203012.84%
Fastest Growing SegmentOral
Largest MarketNorth America

Key Market Drivers

Rising Prevalence of Peanut Allergies

The global rise in peanut allergy cases is a major factor accelerating growth in the peanut allergy treatment market. In Western countries, incidence rates have risen sharply over the last two decades. For example, the prevalence among U.S. children grew from 0.4% in 1997 to 1.4% by 2008, while the UK saw childhood food allergies triple from 1.2% to 4% between 2008 and 2018. This increase has intensified the demand for effective therapeutic solutions. Health authorities such as the CDC have flagged food allergies as a mounting public health concern, advocating for improved diagnostic and treatment frameworks. Parental concern and awareness regarding severe allergic reactions have spurred a push for more advanced interventions. As a result, pharmaceutical companies are intensifying efforts to develop treatments like biologics and immunotherapies to address this critical health issue, further propelling market expansion.

Key Market Challenges

High Cost of Treatment

The high cost associated with peanut allergy therapies remains a major challenge for market penetration and equitable access. Treatments such as immunotherapy and biologics involve high expenses related to drug formulation, administration, monitoring, and managing side effects. These costs may be prohibitive, especially in areas with limited insurance coverage or healthcare funding. Coverage discrepancies in insurance plans exacerbate affordability issues, discouraging patients from pursuing potentially effective care. Public healthcare systems also face budgetary pressures due to the high treatment costs. Overcoming this barrier requires cooperation among pharmaceutical companies, insurers, and government bodies. Implementing measures such as value-based pricing, enhanced insurance reimbursement, and patient support programs is essential to broaden treatment accessibility.

Key Market Players

  • Vedanta Biosciences, Inc.
  • Alladapt Immunotherapeutics, Inc.
  • Regeneron Pharmaceuticals Inc.
  • Aravax Pty Ltd
  • Teva Pharmaceutical Industries Limited
  • Prota Therapeutics Pty Ltd.
  • Aimmune Therapeutics, Inc. (Nestle)
  • DBV Technologies SA
  • Sanofi SA
  • Mylan N.V.

Report Scope:

In this report, the Global Peanut Allergy Treatment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Peanut Allergy Treatment Market, By Drug Class:

  • Antihistamines
  • Epinephrine
  • Immunotherapies
  • Others

Peanut Allergy Treatment Market, By Route of Administration:

  • Oral
  • Intravenous
  • Others

Peanut Allergy Treatment Market, By Distribution Channel:

  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies

Peanut Allergy Treatment Market, By Region:

  • North America
    • United States
    • Mexico
    • Canada
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • India
    • South Korea
    • Japan
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Peanut Allergy Treatment Market.

Available Customizations:

Global Peanut Allergy Treatment Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validations
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Peanut Allergy Treatment Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Drug Class (Antihistamines, Epinephrine, Immunotherapies, Others)
    • 5.2.2. By Route of Administration (Oral, Intravenous, Others)
    • 5.2.3. By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies)
    • 5.2.4. By Region
    • 5.2.5. By Company (2024)
  • 5.3. Product Map
    • 5.3.1. By Drug Class
    • 5.3.2. By Route of Administration
    • 5.3.3. By Distribution Channel
    • 5.3.4. By Region

6. North America Peanut Allergy Treatment Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Drug Class
    • 6.2.2. By Route of Administration
    • 6.2.3. By Distribution Channel
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Peanut Allergy Treatment Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Drug Class
        • 6.3.1.2.2. By Route of Administration
        • 6.3.1.2.3. By Distribution Channel
    • 6.3.2. Canada Peanut Allergy Treatment Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Drug Class
        • 6.3.2.2.2. By Route of Administration
        • 6.3.2.2.3. By Distribution Channel
    • 6.3.3. Mexico Peanut Allergy Treatment Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Drug Class
        • 6.3.3.2.2. By Route of Administration
        • 6.3.3.2.3. By Distribution Channel

7. Europe Peanut Allergy Treatment Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Drug Class
    • 7.2.2. By Route of Administration
    • 7.2.3. By Distribution Channel
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Peanut Allergy Treatment Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Drug Class
        • 7.3.1.2.2. By Route of Administration
        • 7.3.1.2.3. By Distribution Channel
    • 7.3.2. Germany Peanut Allergy Treatment Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Drug Class
        • 7.3.2.2.2. By Route of Administration
        • 7.3.2.2.3. By Distribution Channel
    • 7.3.3. United Kingdom Peanut Allergy Treatment Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Drug Class
        • 7.3.3.2.2. By Route of Administration
        • 7.3.3.2.3. By Distribution Channel
    • 7.3.4. Italy Peanut Allergy Treatment Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Drug Class
        • 7.3.4.2.2. By Route of Administration
        • 7.3.4.2.3. By Distribution Channel
    • 7.3.5. Spain Peanut Allergy Treatment Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Drug Class
        • 7.3.5.2.2. By Route of Administration
        • 7.3.5.2.3. By Distribution Channel

8. Asia-Pacific Peanut Allergy Treatment Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Drug Class
    • 8.2.2. By Route of Administration
    • 8.2.3. By Distribution Channel
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Peanut Allergy Treatment Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Drug Class
        • 8.3.1.2.2. By Route of Administration
        • 8.3.1.2.3. By Distribution Channel
    • 8.3.2. India Peanut Allergy Treatment Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Drug Class
        • 8.3.2.2.2. By Route of Administration
        • 8.3.2.2.3. By Distribution Channel
    • 8.3.3. Japan Peanut Allergy Treatment Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Drug Class
        • 8.3.3.2.2. By Route of Administration
        • 8.3.3.2.3. By Distribution Channel
    • 8.3.4. South Korea Peanut Allergy Treatment Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Drug Class
        • 8.3.4.2.2. By Route of Administration
        • 8.3.4.2.3. By Distribution Channel
    • 8.3.5. Australia Peanut Allergy Treatment Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Drug Class
        • 8.3.5.2.2. By Route of Administration
        • 8.3.5.2.3. By Distribution Channel

9. South America Peanut Allergy Treatment Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Drug Class
    • 9.2.2. By Route of Administration
    • 9.2.3. By Distribution Channel
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Peanut Allergy Treatment Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Drug Class
        • 9.3.1.2.2. By Route of Administration
        • 9.3.1.2.3. By Distribution Channel
    • 9.3.2. Argentina Peanut Allergy Treatment Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Drug Class
        • 9.3.2.2.2. By Route of Administration
        • 9.3.2.2.3. By Distribution Channel
    • 9.3.3. Colombia Peanut Allergy Treatment Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Drug Class
        • 9.3.3.2.2. By Route of Administration
        • 9.3.3.2.3. By Distribution Channel

10. Middle East and Africa Peanut Allergy Treatment Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Drug Class
    • 10.2.2. By Route of Administration
    • 10.2.3. By Distribution Channel
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Peanut Allergy Treatment Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Drug Class
        • 10.3.1.2.2. By Route of Administration
        • 10.3.1.2.3. By Distribution Channel
    • 10.3.2. Saudi Arabia Peanut Allergy Treatment Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Drug Class
        • 10.3.2.2.2. By Route of Administration
        • 10.3.2.2.3. By Distribution Channel
    • 10.3.3. UAE Peanut Allergy Treatment Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Drug Class
        • 10.3.3.2.2. By Route of Administration
        • 10.3.3.2.3. By Distribution Channel

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global Peanut Allergy Treatment Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Vedanta Biosciences, Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Company Snapshot
    • 15.1.3. Products & Services
    • 15.1.4. Financials (As Reported)
    • 15.1.5. Recent Developments
    • 15.1.6. Key Personnel Details
    • 15.1.7. SWOT Analysis
  • 15.2. Alladapt Immunotherapeutics, Inc.
  • 15.3. Regeneron Pharmaceuticals Inc.
  • 15.4. Aravax Pty Ltd
  • 15.5. Teva Pharmaceutical Industries Limited
  • 15.6. Prota Therapeutics Pty Ltd.
  • 15.7. Aimmune Therapeutics, Inc. (Nestle)
  • 15.8. DBV Technologies SA
  • 15.9. Sanofi SA
  • 15.10. Mylan N.V.

16. Strategic Recommendations

17. About Us & Disclaimer